Accurate network pharmacology and novel ingredients formula of herbal targeting estrogen signaling for psoriasis intervention

• Published in: Journal of ethnopharmacology Vol. 329; p. 118099
• Main Authors: Wu, Xinxin, Hu, Sheng, Jia, Ning, Zhang, Caiyun, Liu, Changya, Song, Jiankun, Kuai, Le, Jiang, Wencheng, Li, Bin, Chen, Qilong
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 15-07-2024
• Subjects: Compound; Drugs, Chinese Herbal - chemistry; Drugs, Chinese Herbal - pharmacology; Estrogen signaling pathway; Estrogens - metabolism; Estrogens - pharmacology; HaCaT Cells; Herbal medicine; Humans; Molecular Docking Simulation; Network Pharmacology; Proteomics - methods; Psoriasis; Psoriasis - drug therapy; Psoriasis - metabolism; Signal Transduction - drug effects; TMT-based proteomics; Herbal medicine; TMT-based proteomics; Network pharmacology; Compound; Psoriasis; Estrogen signaling pathway
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2024.118099

As a common chronic inflammatory skin disease, psoriasis is incompletely understood and brings a lot of distress to patients. The estrogen signaling pathway has been implicated in its pathogenesis, making it a potential therapeutic target. Si Cao Formula (SCF) has demonstrated promise in treating psoriasis clinically. However, its molecular mechanisms concerning psoriasis remain largely unexplored.
To elucidate the underlying mechanisms of the action of SCF on psoriasis.
Active ingredients were identified by LC-MS/MS. After the treatment with SCF, the exploration of differentially expressed proteins (DEPs) were conducted using tandem mass tag (TMT)-based quantitative proteomics analysis. By GO/KEGG, WikiPathways and network pharmacology, core signaling pathway and protein targets were explored. Consequently, major signaling pathway and protein targets were validated by RT-qPCR, immunoblotting and immunofluorescence. Based on Lipinski's Rule of Five rules and molecular docking, 8 active compounds were identified that acted on the core targets.
41 compounds of SCF and 848 specific targets of these compounds were identified. There were 570 DEPs between IMQ (Imiquimod) and IMQ + SCF group, including 279 up-regulated and 304 down-regulated proteins. GO/KEGG, WikiPathways and network pharmacology revealed estrogen signaling pathway as the paramount pathways, through which SCF functioned on psoriasis. We further show novel ingredients formula of SCF contributes to estrogen signaling intervention, including liquiritin, parvisoflavone B, glycycoumarin, 8-prenylluteone, licochalcone A, licochalcone B, oxymatrine, and 13-Hydroxylupanine, where targeting MAP2K1, ILK, HDAC1 and PRKACA, respectively. Molecular docking proves that they have good binding properties.
Our results provide an in-depth view of psoriasis pathogenesis and herbal intervention, which expands our understanding of the systemic pharmacology to reveal the multiple ingredients and multiple targets of SCF and focus on one pathway (estrogen signaling pathway) may be a novel therapeutic strategy for psoriasis treatment of herbal medicine.
[Display omitted]
•The research showcases the precision of the formulated herbal treatment (SCF), with multiple potent compounds collaboratively targeting various core nodes within the estrogen signaling pathway, offering a promising avenue for precise and effective psoriasis intervention.•This study, utilizing proteomics and systems pharmacology, focuses on the estrogen signaling pathway, revealing the molecular mechanism of SCF in treating psoriasis.•The research indicates that the various active ingredients of SCF (liquiritin, parvisoflavone B, glycycoumarin, 8-prenylluteone, licochalcone A, licochalcone B, oxymatrine, and 13-Hydroxylupanine) collectively target multiple core targets (MAP2K1, ILK, HDAC1, and PRKACA) within the estrogen signaling, treating psoriasis.